Triggered release of inhaled insulin from the agglomerated vesicles: Pharmacodynamic studies in rats

Journal of Controlled Release

Volumn 113, Issue 2, 2006, Pages 117-127

  Karathanasis, Efstathios ^a,b   Bhavane, Rohan ^b   Annapragada, Ananth V ^a,b  

^a University of Houston   (United States)

^b University of Texas School of Health Information Sciences at Houston   (United States)

Author keywords

Agglomerated vesicle technology; Controlled and triggered release; Inhaled insulin; Liposomes; Rat pharmacodynamics

Indexed keywords

AEROSOLS; CELLS; CROSSLINKING; GLUCOSE; PHARMACODYNAMICS; PROTEINS;

AGGLOMERATED VESICLE TECHNOLOGY; CONTROLLED AND TRIGGERED RELEASE; INHALED INSULIN; LIPOSOMES; RAT PHARMACODYNAMICS;

INSULIN;

ACETYLCYSTEINE; GLUCOSE; INSULIN; KETAMINE; LIPOSOME; XYLAZINE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; DRUG BLOOD LEVEL; EVALUATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN RELEASE; MALE; MEMBRANE DAMAGE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; SUSTAINED DRUG RELEASE;

ADMINISTRATION, INHALATION; ANIMALS; BLOOD GLUCOSE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; INSULIN; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745235269     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.04.004     Document Type: Article

References (30)

1. Gale E.A. Insulin lispro: a new quick-acting insulin analogue. Expert. Opin. Investig. Drugs 6 (1997) 1227-1246
2. Raskin P., Guthrie R.A., Leiter L., Riis A., and Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 23 (2000) 583-588
3. Rosenstock J., Park G., and Zimmerman J. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. Diabetes Care 23 (2000) 1137-1142
4. Portuese E., and Orchard T. Mortality insulin-dependent diabetes. Diabetes in America. 2nd edition (1995), NIH publication 221-232
5. Anderson R.M., Fitzgerald J.T., Wisdom K., Davis W.K., and Hiss R.G. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 20 (1997) 299-305
6. Barnie A., Cleary P., Genuth S., Martin C., Mayfield R., Tamborlane W., Wesche J., and Shamoon H. Epidemiology of Diabetes Interventions and Complications (EDIC): design and implementation of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22 (1999) 99-111
7. Nathan D.M., Lachin J.M., Cleary P., Orchard T., Brillon D.J., Backlund J.Y., O'Leary D.H., and Genuth S.M. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 348 (2003) 2294-2303
8. Skyler J.S. Effects of glycemic control on diabetes complications and on the prevention of diabetes. Clin. Diabetes 22 (2004) 162-166
9. DCCT/EDIC Research Group. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr. 139 (2001) 804-812
10. Jaremko J., and Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 21 (1998) 444-450
11. Jeong S.Y., Kim S.W., Holmberg D.L., and McRea J.C. Self-regulating insulin delivery systems: III. In vivo studies. J. Control. Release 2 (1985) 143-152
12. Kim S.W., Pai C.M., Makino K., Seminoff L.A., Holmberg D.L., Gleeson J.M., Wilson D.E., and Mack E.J. Self-regulated glycosylated insulin delivery. J. Control. Release 11 (1990) 193-201
13. Kim J.J., and Park K. Modulated insulin delivery from glucose-sensitive hydrogel dosage forms. J. Control. Release 77 (2001) 39-47
14. Lin C., Gokhale R., Trivedi J.S., and Ranade V. Recent strategies and methods for improving insulin delivery. Drug Dev. Res. 139 (2004) 151-160
15. Gannslen M. Uber inhalation von insulin. Klin. Wochenschr. (1925) 4-71
16. Wigley F.M., Londono J.H., and Wood J.H. Insulin across respiratory mucosa by aerosol delivery. Diabetes 20 (1971) 552-556
17. Patton J.S., Bukar J.G., and Eldon M.A. Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin. Pharmacokinet. 43 (2004) 781-801
18. Patton J., Bukar J., and Nagarajan S. Inhaled insulin. Adv. Drug Deliv. Rev. 35 (1999) 235-247
19. Nektar "Nektar Reports that FDA Advisory Committee Recommends Approval of Exubera® for Use in Adults with Type 1 and Type 2 Diabetes", Press release, Sep 08, 2005.
20. Edwards D., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M., Mintzes J., Deaver D., Lotan N., and Langer R. Large porous particles for pulmonary drug delivery. Science 276 (1997) 1868-1871
21. Surendrakumar K., Martyn G.P., Hodgers E.C.M., Jansen M., and Blair J.A. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J. Control. Release 91 (2003) 385-394
22. Cook R.O., Pannu R.K., and Kellaway I.W. Novel sustained release microspheres for pulmonary drug delivery. J. Control. Release 104 (2005) 79-90
23. Bhavane R., Karathanasis E., and Annapragada A.V. Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J. Control. Release 93 (2003) 15-28
24. Karathanasis E., Ayyagari A., Bhavane R., Bellamkonda R., and Annapragada A.V. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J. Control. Release 103 (2005) 159-175
25. E. Karathanasis, Modulated delivery of insulin to the lungs, Master's Thesis, Cleveland State University, 2003.
26. Hermanson G. Bioconjugate Techniques (1996), Academic Press, New York
27. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., and Edwards D.A. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16 (1999) 1735-1742
28. Hindlycke M., and Jansson L. Glucose tolerance and pancreatic islet blood flow in rats after intraperitoneal administration of different anesthetic drugs. Ups. J. Med. Sci. 97 (1992) 27-35
29. Lee S., Newnham R.E., and Smith N.B. Short ultrasound exposure times for noninvasive insulin delivery in rats using the lightweight cymbal array. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 51 (2004) 176-180
30. Cefalu W.T., Skyler J.S., Kourides I.A., Landschulz W.H., Balagtas C.C., Cheng S., and Gelfand R.A. Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann. Intern. Med. 134 (2001) 203-207